• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Avik Roy Discusses King v. Burwell and Potential Disruption

Video

Leading up to the Supreme Court's decision in the case of King v. Burwell, Avik Roy, senior fellow at the Manhattan Institute, discusses in what ways Congress should potentially act if the plaintiffs receive a favorable ruling, who is to blame more if subsidies are removed from the federal marketplace, and how much time there will be for a patch to prevent millions of Americans losing financial assistance and subsequently their health insurance.

Leading up to the Supreme Court's decision in the case of King v. Burwell, Avik Roy, senior fellow at the Manhattan Institute, discusses in what ways Congress should potentially act if the plaintiffs receive a favorable ruling, who is to blame more if subsidies are removed from the federal marketplace, and how much time there will be for a patch to prevent millions of Americans losing financial assistance and subsequently their health insurance.

Mr Roy lays the blame for the negative effects that will ensue should the Supreme Court rule in favor of the plaintiffs on both the Obama administration and the Republicans. The adminisrtation is at fault for even creating the situation in the first place, but since Republicans now control Congress, if they do nothing they will be responsible for the outcome.

"So the question is, 'Can Republicans agree on how to [minimize the disruption]?'" he explained. "Because there are different schools of thought. Some conservatives say, 'Don't do anything. Let the disruption happen, it's not our fault.' Others say, 'Well, listen we control the legislative branch, it's up to us to try to come up with a way to handle this problem.'"

Related Videos
Mei Wei, MD.
Milind Desai, MD
Masanori Aikawa, MD
Neil Goldfarb, GPBCH
Sandra Cueller, PharmD
Ticiana Leal, MD
James Chambers, PhD
Mabel Mardones, MD.
Dr Bonnie Qin
Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah.
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.